Episode Details
Back to Episodes
Episode 367: American Academy of Ophthalmology 2022 Meeting Retina Recap
Published 3 years, 7 months ago
Description
Drs. Avni Finn and Shriji Patel join to discuss big takeaways from the 2022 AAO Annual Meeting, including discussion of biosimilars, dry AMD treatments, high-dose aflibercept, and private equity influence in the retina community.
Relevant Financial Disclosures: Dr. Sridhar is a consultant for Alcon, Allergan, Apellis, DORC, Genentech, Ocuterra, and Regeneron. Dr. Finn is a consultant for Allergan and Genentech. Dr. Patel has no relevant disclosures.You can now claim CME credits via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi